Brief: Spectral To Update Timing For Initiation Of Tigris Trial In Near Future
17/12/2018 14:25
Dec 17 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL ANNOUNCES RESULTS OF A FACE-TO-FACE MEETING WITH
THE
U.S. FDA
* SPECTRAL MEDICAL INC - EXPECTS TO UPDATE SHAREHOLDERS IN
NEAR
FUTURE WITH RESPECT TO TIMING FOR INITIATION OF TIGRIS TRIAL
* SPECTRAL MEDICAL INC - "ANNOUNCES RESULT OF A FAVOURABLE
FACE-TO-FACE MEETING WITH U.S. FDA."
Source text for Eikon: ID:nGNX4rVstg
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%